Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma Meeting Abstract
| Authors: | Ribas, A.; Robert, C.; Daud, A.; Hodi, F. S.; Wolchok, J. D.; Kefford, R.; Patnaik, A.; Hwu, W. J.; Weber, J. S.; Joshua, A.; Hersey, P.; Gangadhar, T. C.; Joseph, R. W.; Dronca, R. S.; Zarour, H. M.; Ebbinghaus, S.; Gergich, K.; Li, X.; Kang, S. P.; Hamid, O. |
| Abstract Title: | Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419602710 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.9009 |
| Notes: | Meeting Abstract: 9009 -- Source: Wos |
